News & Articles

Five Prime Therapeutics and Personal Genome Diagnostics collaborate to develop new diagnostic assay for gastric and gastrointestinal cancers

Study in Nature Communications identifies new predictors of patient outcome and suggests targeted therapy approaches may benefit more patients than previously thought.